Immuno-morphological features of endometrial hyperplasic processes

В. М. Запорожан, С. А. Фетеску

Abstract


The aim of the study was to evaluate the immuno-morphological features of endometrial hyperplastic processes by determining the expression of dendritic cells (CD56+, CD83+, CD1a+) and apoptotic factors (Bcl-2 and Вах) in simple and atypical endometrial hyperplasia.

Materials and methods. The study involved 25 women with simple hyperplasia (group I), 25 – atypical hyperplasia (group II), control group consisted of 20 healthy women. Determination of dendritic cells in the endometrial biopsies performed by immunohistochemical method using monoclonal antibodies LIR, Dardilly (France) to CD56+, CD83+, CD1a+. Expression of the antiapoptosis protein Bcl-2 and proapoptosis protein Вах was observed in the cytoplasm of cells and differed in intensity staining.

Results. Immunohistochemical study of endometrial biopsies found that dendritic cells that expressed antigens CD56+, CD83+, CD1a+, showed a high level of expression. In this case, the severity and nature of immune disorders that accompany pathological endometrial transformation depends not only on the severity of its morphological changes, but also on the duration of the procedure (r = 0,61) and the presence of comorbidity (rA = 0,66). At the same time we found that the degree of expression of factors Bcl-2 and Вах was weak to moderate in women with simple and atypical hyperplasia of the endometrium and negative – in healthy women. The level of expression of markers of apoptosis in group II patients correlated (r = 0,54) with the severity of expression of immature dendritic cells CD1a+. This demonstrates the important role of the functional state of dendritic cells in the regulation of cell proliferation and apoptosis activity in women with endometrial hyperplasia.


Keywords


endometrial hyperplasia; dendritic cells; apoptosis

References


Tatarchuk, T.F., Kalugina, L.V. “Question of the endometrial hyperplasia treatment.” Reproductive Endocrinology, 2(4) (2012):88–90.

Dubinina, V.G., Rybin, A.I. “Immune-endocrine relationships among women of reproductive age with different kinds of endometrium transformation.” Bukovynskiy Medical Bulletin, 3(6) (2002): 215–220.

Burlev, V.A., Sarkisov, S.E., Iliasova, N.A., Burlev, A.V. “Eutopic endometrial hyperplasia: atypia and angiogenesis.” Reproduction Problems, 5(2007):21–27.

Nosenko, E.N., Malova, Y.A., Goshkoderia, I.J. et al. “Some characteristics of receptivity and reactive properties of the endometrium in patients with simple non-atypical endometrial hyperplasia.” Bulletin of Emergency and Rehabilitation Medicine, 2(9) (2008): 179–183.

Zaporozhan, V.N., Marinyuk, A.S., Kholodkova, E.L., Andronov, D.Y. “Role of the interfering RNA in the regulation of immune surveillance and proliferative processes on the example of an experimental model of endometrial cancer in pathological conditions of the thyroid gland.” Kazan Medical Journal, 94(3) (2013): E01.

Zaporozhan, V.N., Marichereda, V.G., Dimcheva, L.I. “Risk factors for tumor progression of neoplastic cerviсal lesions.” Journal of Health Sciences, 11(3) (2013).

Shen, Z., Fahey, J.V., Bodwell, J.E., Rodriguez-Garcia, M., Rossoll, R.M., Crist, S.G., Patel, M.V., Wira, C.R. “Estradiol regulation of nucleotidases in female reproductive tract epithelial cells and fibroblasts.” PLoS One, 8(7) (2013): e69854.

Romanovskyi, O.Y. “Endometrial hyperplastic processes of reproductive age (review).” Gynecologist, 8(2005): 9–20.

Berbic, M., Fraser, I.S. “Immunology of normal and abnormal menstruation.” Womens Health (Lond Engl), 9(4) (2013):387–395.

Kyurkchiev, D., Ivanova-Todorova, E., Kyurkchiev, S.D. “New target cells of the immunomodulatory effects of progesterone.” Reprod Biomed Online, 21(3) (2010): 304–311.

Schulke, L., Berbic, M., Manconi, F., Tokushige, N., Markham, R., Fraser, I.S. “Dendritic cell populations in the eutopic and ectopic endometrium of women with endometriosis.” Hum Reprod, 24(7) (2009): 1695–1703.

Kokawa, K., Shikone, T., Nakano, R. “Apoptosis in the human uterine endometrium during the menstrual cycle.” J Clin Endocrinol Metab, 81(11) (1996): 4144–4147.

Jones, R.K., Searle, R.F., Bulmer, J.N. “Apoptosis and bcl-2 expression in normal human endometrium, endometriosis and adenomyosis.” Hum Reprod, 13(12) (1998): 3496–3502.

Order of the MOH of Ukraine of 29.12.2003 № 620 «Organization of inpatient obstetric and neonatal care in Ukraine.» [http://www.moz.gov.ua/ua/main/docs/?docID=6201]. Last accessed March 16, 2015.

Order of the MOH of Ukraine of 31.12.2004 № 676 «Approval of clinical protocols for obstetric and gynecological care.» [http://www.moz.gov.ua/ua/main/docs/?docID=15187]. Last accessed March 16, 2015.

Rebrova, O.Y. Statistical analysis of medical data. Application software package STAT ISTICA . Moscow, MediaSphere (2002): 312 p.


GOST Style Citations


1. Татарчук, Т.Ф. К вопросу о лечении гиперплазии эндометрия / Т.Ф. Татарчук, Л.В. Калугина // Репродуктивная ендокринология. — 2012. — № 2 (4). — С. 88–90.

2. Дубинина, В.Г. Иммуно-эндокринные взаимоотношения у женщин репродуктивного возраста с различными видами трансформации эндометрия / В.Г. Дубинина, А.И. Рыбин // Буковинський медичний вісник. — 2002. — Т. 6, № 3. — С. 215–220.

3. Бурлев, В.А. Гиперплазия эутопического эндометрия: атипия и ангиогенез / В.А. Бурлев, С.Е. Саркисов, Н.А. Ильясова, А.В. Бурлев // Проблемы репродукции. — 2007. — № 5. — С. 21–27. 

4. Носенко, Е.Н. Некоторые характеристики рецептивности и реактивных свойств эндометрия у пациенток с простой неатипической гиперплазией эндометрия / Е.Н. Носенко, Ю.А. Малова, И.Ю. Гошкодеря и др. / Вестник неотложной и восстановительной медицины. — 2008. — Т. 9, № 2. — С. 179–183.

5. Запорожан, В.Н. Роль интерферирующей РНК в регуляции иммунного надзора и пролиферативных процессов на примере экспериментальной модели рака эндометрия в условиях патологии щитовидной железы / В.Н. Запорожан, А.С. Маринюк, Е.Л. Холодкова, Д.Ю. Андронов // Казанский медицинский журнал. — 2013. — Т. 94, № 3. — Е01.

6. Zaporozhan, V.N., Marichereda, V.G., Dimcheva, L.I. “Risk factors for tumor progression of neoplastic cerviсal lesions.” Journal of Health Sciences, 11(3) (2013).

7. Shen, Z., Fahey, J.V., Bodwell, J.E., Rodriguez-Garcia, M., Rossoll, R.M., Crist, S.G., Patel, M.V., Wira, C.R. “Estradiol regulation of nucleotidases in female reproductive tract epithelial cells and fibroblasts.” PLoS One, 8(7) (2013): e69854.

8. Романовский, O.Ю. Гиперпластические процессы эндометрия в репродуктивном периоде (обзор литературы) / О.Ю. Романовский // Гинеколог. — 2005. — №8. — С. 9–20.

9. Berbic, M., Fraser, I.S. “Immunology of normal and abnormal menstruation.” Womens Health (Lond Engl), 9(4) (2013):387–395.

10. Kyurkchiev, D., Ivanova-Todorova, E., Kyurkchiev, S.D. “New target cells of the immunomodulatory effects of progesterone.” Reprod Biomed Online, 21(3) (2010): 304–311.

11. Schulke, L., Berbic, M., Manconi, F., Tokushige, N., Markham, R., Fraser, I.S. “Dendritic cell populations in the eutopic and ectopic endometrium of women with endometriosis.” Hum Reprod, 24(7) (2009): 1695–1703.

12. Kokawa, K., Shikone, T., Nakano, R. “Apoptosis in the human uterine endometrium during the menstrual cycle.” J Clin Endocrinol Metab, 81(11) (1996): 4144–4147.

13. Jones, R.K., Searle, R.F., Bulmer, J.N. “Apoptosis and bcl-2 expression in normal human endometrium, endometriosis and adenomyosis.” Hum Reprod, 13(12) (1998): 3496–3502.

14. Наказ МОЗ України від 29.12.2003 № 620 «Про організацію надання стаціонарної акушерсько-гінекологічної та неонатологічної допомоги в Україні». Режим доступу: [http://www.moz.gov.ua/ua/main/docs/?docID=6201]

15. Наказ МОЗ України від 31.12.2004 № 676 «Про затвердження клінічних протоколів з акушерської та гінекологічної допомоги». Режим доступу: [http://www.moz.gov.ua/ua/main/docs/?docID=15187]

16. Реброва, О.Ю. Статистический анализ медицинских данных. Применение пакета прикладных программ STAT ISTICA / О.Ю. Реброва // М.: МедиаСфера. — 2002. — 312 с.

 





DOI: http://dx.doi.org/10.18370/2309-4117.2015.21.15-18

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2411-1295 (Online), ISSN 2309-4117 (Print)